In the studies including antineoplastic agents without HSCT as exposure, two large studies by Lennard et al. [12] and Wray et al. [13] did not find an association of TPMT variants with SOS after acute lymphoblastic leukemia (ALL) treatment including patients exposed to thioguanine. Here, TPMT is linked to acute lymphoblastic leukemia.